← All trials
NCT05426811
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2022
- Primary completion
- Jul 1, 2025
- Completion date
- Dec 30, 2025
- First posted
- Jun 22, 2022
- Last posted
- Jun 29, 2022
- Enrollment
- 50
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- China Medical UniversityLead sponsor
- Dalian Medical UniversityCollaborator
- Dalian Medical UniversityCollaborator
- Anshan Tumor HospitalCollaborator
- Benxi City hospital of Chinese medicineCollaborator
- China Medical UniversityOverall official - principal investigator
- China Medical UniversityReponsible party - principal investigator
- The People's Hospital of Liaoning ProvinceCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.